These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 39230793

  • 1. The impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances.
    Goodman E, Reuschenbach M, Viering T, Luzak A, Greiner W, Hampl M, Jacob C.
    Arch Gynecol Obstet; 2024 Nov; 310(5):2639-2646. PubMed ID: 39230793
    [Abstract] [Full Text] [Related]

  • 2. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Drolet M, Bénard É, Pérez N, Brisson M, HPV Vaccination Impact Study Group.
    Lancet; 2019 Aug 10; 394(10197):497-509. PubMed ID: 31255301
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L.
    Eur J Cancer; 2015 Sep 10; 51(13):1732-41. PubMed ID: 26121913
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: An ecological analysis on the effects of the school-based human papillomavirus vaccination program.
    Donken R, van Niekerk D, Hamm J, Spinelli JJ, Smith L, Sadarangani M, Albert A, Money D, Dobson S, Miller D, Lee M, Mitchell-Foster S, Krajden M, Naus M, Ogilvie G.
    Int J Cancer; 2021 Jul 01; 149(1):191-199. PubMed ID: 33586169
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
    Rob F, Tachezy R, Pichlík T, Rob L, Kružicová Z, Hamšíková E, Šmahelová J, Hercogová J.
    Dermatol Ther; 2017 Jan 01; 30(1):. PubMed ID: 27723194
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
    FUTURE I/II Study GroupDepatment of Laboratory Medicine, Lund University, Malmö, Sweden. joakim.dillner@med.lu.se, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Maansson R, Lu S, Vuocolo S, Hesley TM, Barr E, Haupt R.
    BMJ; 2010 Jul 20; 341():c3493. PubMed ID: 20647284
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cancers attributable to human papillomavirus infection.
    Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.
    Sex Health; 2010 Sep 20; 7(3):244-52. PubMed ID: 20719211
    [Abstract] [Full Text] [Related]

  • 15. Impact of HPV vaccination: health gains in the Italian female population.
    Marcellusi A.
    Popul Health Metr; 2017 Sep 29; 15(1):36. PubMed ID: 28962572
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study.
    Lazcano-Ponce E, Salmerón J, González A, Allen-Leigh B, León-Maldonado L, Magis C, Aranda-Flores C, Conde-González C, Portillo-Romero AJ, Yunes-Díaz E, Rivera-Rivera L, Vargas G, Nyitray AG, Giuliano AR.
    Salud Publica Mex; 2018 Sep 29; 60(6):703-712. PubMed ID: 30699275
    [Abstract] [Full Text] [Related]

  • 18. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.
    Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C, Brisson M.
    Lancet Infect Dis; 2015 May 29; 15(5):565-80. PubMed ID: 25744474
    [Abstract] [Full Text] [Related]

  • 19. [Expected impact of a quadrivalent HPV vaccine in France].
    Riethmuller D, Prétet JL, Denis F, Aubin F, Pradat P, Clavel C, Dachez R, Gondry J, Carcopino X, Mougin C.
    J Gynecol Obstet Biol Reprod (Paris); 2009 Sep 29; 38(5):389-95. PubMed ID: 19481365
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.